Tumor cell division signal

The term "Tumor cell division signal" is not a recognized canonical name for a specific molecular target, such as a receptor, enzyme, or ion channel. Instead, it serves as a broad, descriptive phrase encompassing the various mitogenic signaling pathways that drive the uncontrolled growth and proliferation of malignant cells (Hanahan and Weinberg, 2011). These pathways, which include the MAPK/ERK, PI3K/Akt/mTOR, and Wnt/beta-catenin cascades, are typically triggered by extracellular growth factors binding to their respective transmembrane receptors (Dhillon et al., 2007; Manning and Cantley, 2007). These signals ultimately converge on the cell cycle machinery, particularly cyclins and cyclin-dependent kinases (CDKs), to facilitate the transition through the G1/S and G2/M checkpoints. Because the term refers to a complex biological process involving hundreds of distinct proteins rather than a single targetable entity, it is considered an incorrect or imprecise designation for a therapeutic target. In drug discovery, specific components of these signaling networks, such as EGFR, BRAF, or CDK4/6, are targeted to achieve therapeutic efficacy while minimizing off-target effects.

Other names

Mitogenic signalProliferation signalOncogenic signaling pathway

N/A